Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer

被引:103
作者
Hashimoto, Masaki [1 ]
Tanaka, Fumihiro [2 ]
Yoneda, Kazue [1 ]
Takuwa, Teruhisa [1 ]
Matsumoto, Seiji [1 ]
Okumura, Yoshitomo [3 ]
Kondo, Nobuyuki [1 ]
Tsubota, Noriaki [4 ]
Tsujimura, Tohru [5 ]
Tabata, Chiharu [6 ]
Nakano, Takashi [6 ]
Hasegawa, Seiki [1 ]
机构
[1] Hyogo Coll Med, Dept Thorac Surg, Nishinomiya, Hyogo 6638501, Japan
[2] Univ Occupat & Environm Hlth, Dept Surg Chest Surg 2, Kitakyushu, Fukuoka 8078555, Japan
[3] Itami City Hosp, Itami, Hyogo, Japan
[4] Hyogo Coll Med, Dept Thorac Oncol, Nishinomiya, Hyogo 6638501, Japan
[5] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan
[6] Hyogo Coll Med, Dept Internal Med, Div Resp Med, Nishinomiya, Hyogo 6638501, Japan
基金
日本学术振兴会;
关键词
Lung cancer; Circulating tumour cell; Pulmonary vein; Surgical manipulation; PERIPHERAL-BLOOD; PROGRESSION; SURVIVAL; SEQUENCE; VEIN;
D O I
10.1093/icvts/ivu048
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: Circulating tumour cells (CTCs) are tumour cells shed from a primary tumour and circulate in the peripheral blood after passing through the drainage vein. In previous studies, we showed that high numbers of CTCs were detected in the drainage pulmonary venous blood of most patients with resectable primary lung cancer, whereas only low numbers of CTCs were detected in the peripheral blood of some patients. Accordingly, this prospective study was conducted to assess changes in CTCs in the drainage pulmonary vein (PV) during lung cancer surgery. METHODS: A total of 30 consecutive peripheral-type primary lung cancer patients who underwent lobectomy (or right upper and middle bilobectomy) through open thoracotomy were included. For each patient, 2.5 ml of blood was sampled from the lobar PV of the primary tumour site before and after surgical manipulation for lobectomy. The CTCs were evaluated quantitatively with the CellSearch (R) system. RESULTS: Before surgical manipulation, CTCs were detected in PV blood in the majority of patients (22 of 30, 73.3%), although CTCs were detected in peripheral blood in only two patients (6.7%). The median number of CTCs in the PV (pvCTC-count) before surgical manipulation was 4.0 cells/2.5 ml, and there was no significant correlation between pvPV-count and any clinicopathological characteristic, including tumour size, progression and histological type. After surgical manipulation, at the time of completion of the lobectomy, the pvCTC-count significantly increased (median, 60.0 cells/2.5 ml; P = 0.001). The increase in pvCTC-count was significantly associated with microscopic lymphatic tumour invasion (ly); pvCTC-count significantly increased in ly-positive patients (pvCTC-count before and after surgical manipulation, 4.0 and 90.5 cells/2.5 ml, respectively; P = 0.006), but not in ly-negative patients (3.5 and 7.0 cells/2.5 ml, respectively; P = 0.153). The increase in pvCTC-count was not significantly associated with any other clinicopathological factor or with any surgical procedure, including the sequence of vessel interruption. CONCLUSIONS: We documented a significant increase in CTC count in drainage PV blood after surgical manipulation, especially in tumours with lymphatic invasion. We are awaiting survival data at 5 year follow-up examination, which may provide clinical significance of the pvCTC-count.
引用
收藏
页码:775 / 782
页数:8
相关论文
共 24 条
[1]   Circulating tumor cells and bone marrow micrometastasis [J].
Alix-Panabieres, Catherine ;
Riethdorf, Sabine ;
Pantel, Klaus .
CLINICAL CANCER RESEARCH, 2008, 14 (16) :5013-5021
[2]   Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J].
Allard, WJ ;
Matera, J ;
Miller, MC ;
Repollet, M ;
Connelly, MC ;
Rao, C ;
Tibbe, AGJ ;
Uhr, JW ;
Terstappen, LWMM .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6897-6904
[3]   AVOIDABLE VASCULAR SPREAD IN RESECTION FOR BRONCHIAL CARCINOMA [J].
AYLWIN, JA .
THORAX, 1951, 6 (03) :250-267
[4]   Brain metastases secondary to tumor emboli from primary lung cancer during lobectomy [J].
Cho, Yasushi ;
Hida, Yasuhiro ;
Kaga, Kichizo ;
Kato, Hiroaki ;
Iizuka, Mikiya ;
Kondo, Satoshi .
ANNALS OF THORACIC SURGERY, 2008, 86 (01) :312-313
[5]   Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer [J].
Cristofanilli, M ;
Hayes, DF ;
Budd, GT ;
Ellis, MJ ;
Stopeck, A ;
Reuben, JM ;
Doyle, GV ;
Matera, J ;
Allard, WJ ;
Miller, MC ;
Fritsche, HA ;
Hortobagyi, GN ;
Terstappen, LWMM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) :1420-1430
[6]   Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].
Cristofanilli, M ;
Budd, GT ;
Ellis, MJ ;
Stopeck, A ;
Matera, J ;
Miller, MC ;
Reuben, JM ;
Doyle, GV ;
Allard, WJ ;
Terstappen, LWMM ;
Hayes, DF .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :781-791
[7]   The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours [J].
Goldstraw, Peter ;
Crowley, John ;
Chansky, Kari ;
Giroux, Dorothy J. ;
Groome, Patti A. ;
Rami-Porta, Ramon ;
Postmus, Pieter E. ;
Rusch, Valerie ;
Sobin, Leslie .
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) :706-714
[8]   The sequence of vessel ligation affects tumor release into the circulation [J].
Kurusu, Y ;
Yamashita, J ;
Hayashi, N ;
Mita, S ;
Fujino, N ;
Ogawa, M .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (01) :107-113
[9]  
Meropol NJ, 2007, J CLIN ONCOL, V25
[10]   Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer [J].
Naito, Tateaki ;
Tanaka, Fumihiro ;
Ono, Akira ;
Yoneda, Kazue ;
Takahashi, Toshiaki ;
Murakami, Haruyasu ;
Nakamura, Yukiko ;
Tsuya, Asuka ;
Kenmotsu, Hirotsugu ;
Shukuya, Takehito ;
Kaira, Kyoichi ;
Koh, Yasuhiro ;
Endo, Masahiro ;
Hasegawa, Seiki ;
Yamamoto, Nobuyuki .
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (03) :512-519